Use of direct oral anti-coagulants for the treatment of venous thromboembolism in patients with advanced cancer: a prospective observational study

ConclusionsOur findings confirm the risk of bleeding during DOAC treatment for VTE in Japanese patients with advanced cancer, particularly those with poor PS and those using NSAIDs. The risk of bleeding in these patients may be reduced by avoiding the combined use of DOACs and NSAIDs.

http://link.springer.com/10.1007/s10147-019-01415-z

Source: International Journal of Clinical Oncology - February 12, 2019 Category: Cancer & Oncology Source Type: research